» Articles » PMID: 28351086

Independent Risk Factors Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma

Overview
Journal Horm Metab Res
Specialty Endocrinology
Date 2017 Mar 29
PMID 28351086
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of papillary thyroid microcarcinoma (PTMC) has risen rapidly in recent years, and PTMC patients with central lymph node metastasis (CLNM) usually have poor prognosis. Independent risk factors predicting CLNM in PTMC have not been well understood. The aim of our study was to identify useful clinicopathological risk factors predicting CLNM in PTMC patients. This was a retrospective study of 917 patients with PTMC treated with surgery from January 2014 to December 2015 in our hospital. The relationship between clinicopathological factors and CLNM was analyzed to identify those factors predicting CLNM in PTMC. Univariate and multivariate logistic regression analyses were further performed. Of 917 PTMC patients, 344 (37.5%) were found to have CLNM confirmed by intraoperative frozen-section examination. Multivariate logistic regression analyses further found several independent factors predicting CLNM in PTMC patients, including male gender (OR=1.75, 95% CI 1.17-2.61; p=0.006), younger age (<45 years) (OR=1.69, 95%CI 1.20-2.38; p=0.002), positive CLNM on ultrasonography (OR=10.20, 95% CI 5.51-18.88; p<0.001), multifocality (OR=1.69, 95% CI 1.00-2.85; p=0.04), and larger tumor size (>5 mm) (OR=2.80, 95% CI 2.01-3.91; p<0.001). The findings of our study identified several useful and independent risk factors predicting CLNM in PTMC patients, such as male gender, younger age, multifocality, positive CLNM on ultrasonography, and larger tumor size. The CLNM is very common in PTMC patients, and routine prophylactic central neck dissection may be recommended in PTMC patients with those independent risk factors of CLNM.

Citing Articles

Preoperative circulating tumor cells level is associated with lymph node metastasis in patients with unifocal papillary thyroid carcinoma.

Gu Y, Yu M, Deng J, Lai Y World J Surg Oncol. 2025; 23(1):47.

PMID: 39934782 PMC: 11816784. DOI: 10.1186/s12957-025-03702-8.


Construction and validation of nomograms to predict central lymph node metastasis in clinical node-negative unilateral papillary thyroid carcinoma.

Hu L, Qian B, Zhu J, Gao S, Mei L, Ruan S Sci Rep. 2025; 15(1):2662.

PMID: 39837926 PMC: 11751388. DOI: 10.1038/s41598-025-86201-w.


Prediction model construction of cervical central lymph node metastasis in papillary thyroid carcinoma combined with Hashimoto's thyroiditis utilizing conventional ultrasound and elastography.

Zhao J, Li L, Gao L, Zhang H, Zhou L, Zhu X Gland Surg. 2025; 13(12):2325-2334.

PMID: 39822354 PMC: 11733641. DOI: 10.21037/gs-24-271.


Risk nomogram for papillary thyroid microcarcinoma with central lymph node metastasis and postoperative thyroid function follow-up.

Huang Y, Lou P, Li H, Li Y, Ma L, Wang K Front Endocrinol (Lausanne). 2024; 15:1395900.

PMID: 39530115 PMC: 11550994. DOI: 10.3389/fendo.2024.1395900.


Preoperative High Level of Circulating Tumor Cells is an Independent Risk Factor for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma with Maximum Lesion Diameter ≤1.0 cm.

Yu M, Deng J, Gu Y, Lai Y Int J Gen Med. 2024; 17:4907-4916.

PMID: 39473633 PMC: 11520918. DOI: 10.2147/IJGM.S487992.